Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells

Journal of Experimental Medicine

Volumn 186, Issue 1, 1997, Pages 159-164

  Mathisen, Peter M ^a   Yu, Min ^a   Johnson, Justin M ^a   Drazba, Judith A ^a   Tuohy, Vincent K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DEMYELINATING DISEASE; FLOW CYTOMETRY; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; IMMUNOGENETICS; MEMORY CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; DNA; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-10; MICE; MICE, TRANSGENIC; T-LYMPHOCYTES;

EID: 0030738659     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.1.159     Document Type: Article

References (26)

1. Martin, R., H.F. McFarland, and D.E. McFarlin. 1992. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:153-187.
2. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin the central nervous system. Cell. 85:299-302.
3. Lisak, R.P. 1980. Multiple sclerosis: evidence for immunopathogenesis. Neurology. 30:99-105.
4. McFarlin, D.E., and H.F. McFarland. 1982. Multiple sclerosis (first of two parts). N. Engl. J. Med. 307:1183-1188.
5. Kuchroo, V.K., M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: applications to autoimmune disease therapy. Cell. 80:707-718.
6. Fiorentino, D.F., M.W. Bond, and T.R. Mosmann. 1989. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081-2095.
7. Moore, K.W., P. Vieira, D.F. Fiorentino, M.L. Trounstine, T.A. Khan, and T.R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to Epstein-Barr virus gene BCRFI. Science (Wash. DC). 24:1230-1234.
8. Vieira, P., R. de Waal-Malefyt, and M.-N. Dang. 1991. Isolation and expression of human cytokine synthesis inhibitory factor (CSIF/IL10) cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. USA. 88:1172-1176.
9. Kennedy, M.K., D.S. Torrance, K.S. Picha, and K.M. Mohler. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149:2496-2505.
10. Rott, O., B. Fleischer, and E. Cash. 1994. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24:1434-1440.
11. Novak, T.J., P.M. White, and E.V. Rothenberg. 1990. Regulatory anatomy of the murine interleukin-2 gene. Nucleic Acids Res. 18:4523-4533.
12. Aubin, R.A., M. Weinfeld, R. Mirzayans, and M.C. Paterson. 1994. Polybrene/DMSO-assisted gene transfer. Mol. Biotech. 1:29-48.
13. Chisholm, O., and G. Symonds. 1988. Transfection of myeloid cell lines using polybrene/DMSO. Nucleic Acids Res. 16: 23523.
14. Mathisen, P.M., and L. Miller. 1987. Thyroid hormone induction of keratin genes: a two-step activation of gene expression during development. Genes Dev. 1:1107-1117.
15. Chirgwin, J.M., A.E. Przybyla, R.J. MacDonald, and W.J. Rutter. 1979. Isolation of biologically active RNA from sources enriched in ribonucleases. Biochemistry. 18:5294-5299.
16. Chomczynski, P. 1993. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques. 15:532-537.
17. Tuohy, V.K., Z. Lu, R.A. Sobel, R.A. Laursen, and M.B. Lees. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142: 1523-1526.
18. Qin, L., K.D. Chavin, Y. Ding, H. Tahara, J.P. Favaro, J.E. Woodward, T. Suzuki, P.D. Robbins, M.T. Lotze, and J.S. Bromberg. 1996. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J. Immunol. 156:2316-3232.
19. Bessis, N., M.C. Boissier, P. Ferrera, T. Blankenstein, D. Fradelizi, and C. Fournier. 1996. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur. J. Immunol. 26:2399-2403.
20. Wogensen, L., M.S. Lee, and N. Sarvetnick. 1994. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice. J. Exp. Med. 179:1379-1384.
21. Khoruts, A., S.D. Miller, and M.K. Jenkins. 1995. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced effector Th1 cells. J. Immunol. 155:5011-5017.
22. van der Veen, R.C., and S.A. Stohlman. 1993. Encephalitogenic ThI cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10. J. Neuroimmunol. 48:213-220.
23. Cannella, B., Y.L. Gao, C. Brosman, and C.S. Raine. 1996. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45:735-746.
24. Shaw, M.K., J.B. Lorens, A. Dhawan, R. DalCanto, H.Y. Tse, C. Bonpane, S.L. Eswaran, S. Brocke, N. Sarvetnick, L. Steinman, G.P. Nolan, and C.G. Fathman. 1997. Local delivery of interleukin-4 by retrovirus-transduced lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1541-1547.
25. Kramer, R., Y. Zhang, J. Gehrmann, R. Gold, H. Thoenen, and H. Wekerle. 1995. Gene transfer through the bloodnerve barrier: NGF-engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis. Nature Med. 1: 1162-1166.
26. Tuohy, V.K., and D.M. Thomas. 1995. Sequence of 104-117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice. J. Neuroimmunol. 56: 161-170.